PHARM vs QURE: Side-by-Side Comparison
Compare Pharming Group NV (PHARM) and uniQure N.V. (QURE) side by side: market cap EUR 829.85M vs USD 2.64B. Financials, growth and model signals on Bullrun.
| Metric | PHARM | QURE |
|---|---|---|
| Company | Pharming Group NV | uniQure N.V. |
| Country / Exchange | Netherlands · AS | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 829.85M | USD 2.64B |
| P/E ratio | 83.0 | — |
| Dividend yield | — | — |
| Valuation model | 48.1% overvalued | — |
| Revenue (FY2025) | USD 376.13M | USD 16.10M |
| Revenue growth YoY | +26.6% | -40.6% |
| Net income | USD 2.54M | USD -199.00M |
| Gross margin | 87.9% | 89.5% |
| Diluted EPS | 0.00 | -3.46 |